Corticosteroids

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
Cécile Gaujoux-Viala, Jackie Nam, Sofia Ramiro, Robert Landewé, Maya H Buch, Josef S Smolen, Laure Gossec

Annals of the Rheumatic Diseases Mar 2014, 73 (3) 510-515; DOI: 10.1136/annrheumdis-2013-204588
Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis
Marc Corbera-Bellalta, Ana García-Martínez, Ester Lozano, Ester Planas-Rigol, Itziar Tavera-Bahillo, Marco A Alba, Sergio Prieto-González, Montserrat Butjosa, Georgina Espígol-Frigolé, José Hernández-Rodríguez, Pedro L Fernández, Pascale Roux-Lombard, Jean-Michel Dayer, Mahboob U Rahman, Maria C Cid

Annals of the Rheumatic Diseases Mar 2014, 73 (3) 616-623; DOI: 10.1136/annrheumdis-2012-202883
Successful treatment of combined proliferative and membranous lupus nephritis using a full corticosteroid-free regimen
Bruno Tedeschi, Laurent Arnaud, Miguel Hie, Alexis Mathian, Zahir Amoura

Annals of the Rheumatic Diseases Feb 2014, 73 (2) 474-475; DOI: 10.1136/annrheumdis-2013-204385
Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial
H Haibel, C Fendler, J Listing, J Callhoff, J Braun, J Sieper

Annals of the Rheumatic Diseases Jan 2014, 73 (1) 243-246; DOI: 10.1136/annrheumdis-2012-203055
The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA
Jakub Závada, Mark Lunt, Rebecca Davies, Audrey SL Low, Louise K Mercer, James B Galloway, Kath D Watson, Deborah P Symmons, Kimme L Hyrich, on behalf of the British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium

Annals of the Rheumatic Diseases Jan 2014, 73 (1) 252-255; DOI: 10.1136/annrheumdis-2012-203102
Are steroids required for induction therapy and relapses in lupus nephritis?
Carlos Abud-Mendoza, Roberto González-Amaro

Annals of the Rheumatic Diseases Dec 2013, 72 (12) e29; DOI: 10.1136/annrheumdis-2013-204321
Response to ‘Are steroids required for induction therapy and relapses in lupus nephritis?’ by Abud-Mendoza et al
Marie Condon

Annals of the Rheumatic Diseases Dec 2013, 72 (12) e30; DOI: 10.1136/annrheumdis-2013-204331
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
N Duru, M C van der Goes, J W G Jacobs, T Andrews, M Boers, F Buttgereit, N Caeyers, M Cutolo, S Halliday, J A P Da Silva, J R Kirwan, D Ray, J Rovensky, G Severijns, R Westhovens, J W J Bijlsma

Annals of the Rheumatic Diseases Dec 2013, 72 (12) 1905-1913; DOI: 10.1136/annrheumdis-2013-203249
Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study
Pascal Hendrik Pieter de Jong, Rogier A Quax, Margriet Huisman, A H Gerards, Richard A Feelders, Peter B de Sonnaville, Jolanda J Luime, Angelique E Weel, J M Hazes

Annals of the Rheumatic Diseases Oct 2013, 72 (10) 1659-1663; DOI: 10.1136/annrheumdis-2012-202152
Drug therapy in undifferentiated arthritis: a systematic literature review
K V C Wevers-de Boer, L Heimans, T W J Huizinga, C F Allaart

Annals of the Rheumatic Diseases Sep 2013, 72 (9) 1436-1444; DOI: 10.1136/annrheumdis-2012-203165

Main menu

Corticosteroids

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Corticosteroids

Pages